(1)
Wagg, A.; Franks, B.; Ramos, B.; Berner, T. Persistence and Adherence With the New Beta-3 Receptor Agonist, Mirabegron, Versus Antimuscarinics in Overactive Bladder: Early Experience in Canada. CUAJ 2015, 9, 343-50.